Fact CheckerSign in

NCT07857031Active, not recruiting

EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation

EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation (EXIT-CVD)

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

This prospective, single-center interventional imaging study aims to evaluate the diagnostic performance of Photon Counting Computed Tomography (PCCT) combined with artificial intelligence-based Quantitative Coronary CT (AI-QCT) analysis in patients with suspected or known coronary artery disease (CAD).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
300 (actual)
First submitted
16 Sept 2026
Start date
1 Sept 2026
Primary completion date
1 Jan 2028
Lead sponsor
Centro Cardiologico Monzino
NCT number
NCT07857031

What you commit to

  • Study type: Interventional
  • Participants enrolled: 300
  • From 1 Sept 2026 to the primary completion date, 1 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant arrhythmias impairing image acquisition quality.

Lab values

  • Severe renal impairment (eGFR \<30 mL/min/1.73 m²)

Other

  • Contraindications to CT imaging or iodinated contrast media
  • Pregnancy or breastfeeding.
  • Hemodynamic instability or inability to undergo CT acquisition
  • Inability to provide informed consent.

Who the study is looking for

  • Adults (≥ 18 years)
  • Patients with suspected or known CAD and a positive conventional coronary CT angiography requiring further invasive evaluation.
  • Patients scheduled for clinically indicated invasive coronary angiography with IVUS assessment.
  • Ability to under go an additional PCCT scan according to the study protocol
  • Ability and willingness to provide written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centro Cardiologico Monzino IRCCS
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.